Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan L Longo

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Best Practice & Research. Clinical Haematology|December 13, 2023
Hodgkin lymphoma: Focus on evolving treatment paradigmsJoseph L Roswarski, Dan L Longo
JAMA|March 19, 2019
The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy EfficacyWilliam J Murphy, Dan L Longo
Journal of the National Cancer Institute|December 23, 2011
Follicular lymphoma: to treat or not to treat is no longer the questionCaron A Jacobson, Dan L Longo
The New England Journal of Medicine|October 26, 2012
Talking with patients about dyingThomas J Smith, Dan L Longo
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 28, 2006
A report card for geriatric oncology: borderline pass, improvement neededWilliam B Ershler, Dan L Longo
The New England Journal of Medicine|February 2, 2013
Talking with patients about dyingThomas J Smith, Dan L Longo
The New England Journal of Medicine|July 13, 2022
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?Dan L Longo, James O Armitage
The New England Journal of Medicine|August 8, 2014
PALB2 mutations and breast-cancer riskMichele K Evans, Dan L Longo
The New England Journal of Medicine|October 5, 2017
Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?James O Armitage, Dan L Longo
The New England Journal of Medicine|October 22, 2015
Drug-Induced Megaloblastic AnemiaCharles S Hesdorffer, Dan L Longo
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Best Practice & Research. Clinical Haematology|December 13, 2023
Hodgkin lymphoma: Focus on evolving treatment paradigmsJoseph L Roswarski, Dan L Longo
JAMA|March 19, 2019
The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy EfficacyWilliam J Murphy, Dan L Longo
Journal of the National Cancer Institute|December 23, 2011
Follicular lymphoma: to treat or not to treat is no longer the questionCaron A Jacobson, Dan L Longo
The New England Journal of Medicine|October 26, 2012
Talking with patients about dyingThomas J Smith, Dan L Longo
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 28, 2006
A report card for geriatric oncology: borderline pass, improvement neededWilliam B Ershler, Dan L Longo
The New England Journal of Medicine|February 2, 2013
Talking with patients about dyingThomas J Smith, Dan L Longo
The New England Journal of Medicine|July 13, 2022
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma?Dan L Longo, James O Armitage
The New England Journal of Medicine|August 8, 2014
PALB2 mutations and breast-cancer riskMichele K Evans, Dan L Longo
The New England Journal of Medicine|October 5, 2017
Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?James O Armitage, Dan L Longo
The New England Journal of Medicine|October 22, 2015
Drug-Induced Megaloblastic AnemiaCharles S Hesdorffer, Dan L Longo
Pageof 22